New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.

MLA

Ersoy, Tunc F., et al. “New Prognostic Factor Telomerase Reverse Transcriptase Promotor Mutation Presents without MR Imaging Biomarkers in Primary Glioblastoma.” Neuroradiology, vol. 59, no. 12, Dec. 2017, pp. 1223–31. EBSCOhost, https://doi.org/10.1007/s00234-017-1920-1.

APA

Ersoy, T. F., Keil, V. C., Hadizadeh, D. R., Gielen, G. H., Fimmers, R., Waha, A., Heidenreich, B., Kumar, R., Schild, H. H., & Simon, M. (2017). New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma. Neuroradiology, 59(12), 1223–1231. https://doi.org/10.1007/s00234-017-1920-1

Chicago

Ersoy, Tunc F, Vera C Keil, Dariusch R Hadizadeh, Gerrit H Gielen, Rolf Fimmers, Andreas Waha, Barbara Heidenreich, Rajiv Kumar, Hans H Schild, and Matthias Simon. 2017. “New Prognostic Factor Telomerase Reverse Transcriptase Promotor Mutation Presents without MR Imaging Biomarkers in Primary Glioblastoma.” Neuroradiology 59 (12): 1223–31. doi:10.1007/s00234-017-1920-1.